ARTICLE | Company News
Management tracks: Allergan, Arix, Quest, SurModics
February 20, 2019 12:10 AM UTC
Allergan plc (NYSE:AGN) appointed Robert Hugin to its board. He stepped down as CEO of Celgene Corp. (NASDAQ: CELG) in 2016, and retired as Celgene's executive chairman last year. Mark Alles is Celgene's current chairman and CEO.
In January, Bristol-Myers Squibb Co. (NYSE:BMY) proposed to acquire Celgene for $74 billion in a cash and stock deal (see "Bristol-Myers' Next Phoenix Act?"). ...